Financial insights of NGNE

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30	2025-06-30	2024-12-31	2024-09-30
Revenue under licensing agreements	0	0	0	-
Research and development expenses	17,241	19,366	14,444	16,285
General and administrative expenses	6,557	6,715	5,702	5,895
Total operating expenses	23,798	26,081	20,146	22,180
Loss from operations	-23,798	-26,081	-20,145	-22,180
Interest income	2,739	2,928	2,295	1,842
Interest expense	1	1	3	3
Other income	149	1,212	144	143
Other expense	42	74	508	19
Net loss	-20,953	-22,016	-18,217	-20,217

Net loss per share, basic (in dollars per share)	-0.99	-1.05	-1	-1.19
Net loss per share, diluted (in dollars per share)	-0.99	-1.05	-1	-1.19
Weighted-average shares of common stock outstanding, basic (in shares)	21,168,431	21,055,378	-8,163,942.5	16,953,443
Weighted-average shares of common stock outstanding, diluted (in shares)	21,168,431	21,055,378	-8,163,942.5	16,953,443